• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Use and outcomes of newer chemotherapeutic agents in colorectal cancer patients using Irinotecan as a case study

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Find Full text
    Author
    Obeidat, Nour A.
    Advisor
    Mullins, C. Daniel
    Date
    2008
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    Background. This study sought to identify the existence of disparities in the use of newer chemotherapy and to measure the clinical and economic impact of such therapy in SEER-Medicare colorectal cancer (CRC) patients. Methods. Data on stage II, III, IV and unknown stage SEER-Medicare patients diagnosed with CRC between 1998 and 2002 were used. Irinotecan (IR), marketed at the start of the study period, was defined as 'new' therapy. Descriptive statistics were generated and a multivariable logistic regression run to estimate odds of IR receipt in older patients (vs. younger ones), and in nonwhite races (vs. white) within the first two months of chemotherapy initiation. Cox proportional hazards modeling was used to estimate the survival benefit associated with IR use; a descriptive analysis of Medicare payments and a two-part multivariable regression analysis evaluating the association of IR use within a chemotherapy episode with supportive drug payments made by Medicare within that episode also were run.;Results. The final patient sample was composed of 34,863 stage II, III, IV and unknown stage CRC patients. Among chemotherapy users (14,189), use of IR as a first regimen was observed primarily in stage IV patients---approximately 25% of the 3,327 chemotherapy-using stage IV patients initiated therapy with IR. Consequently, all further analyses were applied to stage IV patients. With respect to disparities, older patients and black patients were significantly less likely to receive IR than younger patients and white patients, respectively. The age disparity was modified by gender. With respect to the survival benefit of IR, a clear significant advantage could not be shown. The economic impact of IR was substantial in terms of direct drug costs; IR-users also were significantly more likely to incur costs due to increased use of supportive drugs. Conclusion. The data suggested the existence of age and racial disparities in the receipt of newer chemotherapy as exemplified by IR. Given use of IR, no significant benefit was observed for the agent, although payments for supportive drugs increased. Some limitations to the study existed, including generalizability, and lack of information on certain variables such as patient preferences.
    Description
    University of Maryland, Baltimore. Pharmaceutical Health Services Research. Ph.D. 2008
    Keyword
    Health Sciences, Pharmacy
    Health Sciences, Oncology
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/994
    Collections
    Theses and Dissertations All Schools
    Theses and Dissertations School of Pharmacy

    entitlement

     
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.